Journal: Pharmaceutics

Article Title: Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects

doi: 10.3390/pharmaceutics14091807

Figure Lengend Snippet: Formulation strategies to overcome fast-fed variability: prodrugs, cyclodextrins, osmotic delivery systems, amorphous solid dispersions, nanocrystal technology, and lipid-based systems.

Article Snippet: 22. , Emend ® , Aprepitant , Nanocrystal , Merck & Co., Inc., Rahway, NJ, USA.

Techniques:

Journal: Pharmaceutics

Article Title: Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects

doi: 10.3390/pharmaceutics14091807

Figure Lengend Snippet: Marketed formulations with innovators who have successfully diminished fast-fed variability.

Article Snippet: 22. , Emend ® , Aprepitant , Nanocrystal , Merck & Co., Inc., Rahway, NJ, USA.

Techniques:

Journal: Pharmaceutics

Article Title: Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects

doi: 10.3390/pharmaceutics14091807

Figure Lengend Snippet: Comparison of mean plasma concentrations of MK-0869 after oral dosing in beagle dogs ( n = 5) of suspension (●, fasted; o, fed) with NanoCrystal ® dispersion formulation (▾, fasted; ▿, fed). Reprinted with permission from Ref. . Copyright 2004, Elsevier.

Article Snippet: 22. , Emend ® , Aprepitant , Nanocrystal , Merck & Co., Inc., Rahway, NJ, USA.

Techniques:

Journal: Pharmaceutics

Article Title: Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects

doi: 10.3390/pharmaceutics14091807

Figure Lengend Snippet: Formulation approaches for reducing fast-fed state variability with pharmacokinetic data.

Article Snippet: 22. , Emend ® , Aprepitant , Nanocrystal , Merck & Co., Inc., Rahway, NJ, USA.

Techniques:

Journal: Pharmaceutics

Article Title: Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects

doi: 10.3390/pharmaceutics14091807

Figure Lengend Snippet: Patents filed exclusively to reduce fast-fed variability.

Article Snippet: 22. , Emend ® , Aprepitant , Nanocrystal , Merck & Co., Inc., Rahway, NJ, USA.

Techniques:

Journal: Pharmaceutics

Article Title: Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects

doi: 10.3390/pharmaceutics14091807

Figure Lengend Snippet: Formulation strategies to overcome fast-fed variability: prodrugs, cyclodextrins, osmotic delivery systems, amorphous solid dispersions, nanocrystal technology, and lipid-based systems.

Article Snippet: 23. , Triglide ® , Fenofibrate , Nanocrystal , Skye Pharma Inc., San Diego, CA, USA.

Techniques: Formulation

Journal: Pharmaceutics

Article Title: Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects

doi: 10.3390/pharmaceutics14091807

Figure Lengend Snippet: Marketed formulations with innovators who have successfully diminished fast-fed variability.

Article Snippet: 23. , Triglide ® , Fenofibrate , Nanocrystal , Skye Pharma Inc., San Diego, CA, USA.

Techniques: Drug Formulation, Dispersion, Formulation

Journal: Pharmaceutics

Article Title: Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects

doi: 10.3390/pharmaceutics14091807

Figure Lengend Snippet: Comparison of mean plasma concentrations of MK-0869 after oral dosing in beagle dogs ( n = 5) of suspension (●, fasted; o, fed) with NanoCrystal ® dispersion formulation (▾, fasted; ▿, fed). Reprinted with permission from Ref. . Copyright 2004, Elsevier.

Article Snippet: 23. , Triglide ® , Fenofibrate , Nanocrystal , Skye Pharma Inc., San Diego, CA, USA.

Techniques: Comparison, Clinical Proteomics, Suspension, Dispersion, Formulation

Journal: Pharmaceutics

Article Title: Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects

doi: 10.3390/pharmaceutics14091807

Figure Lengend Snippet: Formulation approaches for reducing fast-fed state variability with pharmacokinetic data.

Article Snippet: 23. , Triglide ® , Fenofibrate , Nanocrystal , Skye Pharma Inc., San Diego, CA, USA.

Techniques: Formulation, Dispersion

Journal: Pharmaceutics

Article Title: Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects

doi: 10.3390/pharmaceutics14091807

Figure Lengend Snippet: Patents filed exclusively to reduce fast-fed variability.

Article Snippet: 23. , Triglide ® , Fenofibrate , Nanocrystal , Skye Pharma Inc., San Diego, CA, USA.

Techniques: Formulation, Dispersion, Membrane, Emulsion

Journal: Scientific Reports

Article Title: Penternary chalcogenides nanocrystals as catalytic materials for efficient counter electrodes in dye-synthesized solar cells

doi: 10.1038/srep29207

Figure Lengend Snippet: ( a ) XRD Patterns and ( b ) Raman spectrums of Cu 2 CoSn(SeS) 4 and Cu 2 ZnSn(SeS) 4 nanocrystals at room temperature. ( c ) FTIR spectra of oleylamine and both nanocrystals.

Article Snippet: The X-ray diffraction (XRD) pattern of the nanocrystals was recorded with a Bruker Advance D8 diffractometer (Cu a source with 1.5406 wavelength) in powder mode.

Techniques:

Journal: Scientific Reports

Article Title: Penternary chalcogenides nanocrystals as catalytic materials for efficient counter electrodes in dye-synthesized solar cells

doi: 10.1038/srep29207

Figure Lengend Snippet: ( a,b ) TEM images, ( c,d ) HR-TEM images, ( e,f ) SAED patterns and ( g,h ) EDS spectra of Cu 2 CoSn(SeS) 4 and Cu 2 ZnSn(SeS) 4 nanocrystals, respectively.

Article Snippet: The X-ray diffraction (XRD) pattern of the nanocrystals was recorded with a Bruker Advance D8 diffractometer (Cu a source with 1.5406 wavelength) in powder mode.

Techniques:

Journal: Scientific Reports

Article Title: Penternary chalcogenides nanocrystals as catalytic materials for efficient counter electrodes in dye-synthesized solar cells

doi: 10.1038/srep29207

Figure Lengend Snippet: ( a ) UV-Vis absorption spectrums and ( b ) eV Diagrams of Cu 2 CoSn(SeS) 4 and Cu 2 ZnSn(SeS) 4 nanocrystals.

Article Snippet: The X-ray diffraction (XRD) pattern of the nanocrystals was recorded with a Bruker Advance D8 diffractometer (Cu a source with 1.5406 wavelength) in powder mode.

Techniques:

Journal: Scientific Reports

Article Title: Penternary chalcogenides nanocrystals as catalytic materials for efficient counter electrodes in dye-synthesized solar cells

doi: 10.1038/srep29207

Figure Lengend Snippet: Cylic voltammograms for Cu 2 CoSn(SeS) 4 and Cu 2 ZnSn(SeS) 4 nanocrystals and Pt counter electrodes.

Article Snippet: The X-ray diffraction (XRD) pattern of the nanocrystals was recorded with a Bruker Advance D8 diffractometer (Cu a source with 1.5406 wavelength) in powder mode.

Techniques:

Journal: Scientific Reports

Article Title: Penternary chalcogenides nanocrystals as catalytic materials for efficient counter electrodes in dye-synthesized solar cells

doi: 10.1038/srep29207

Figure Lengend Snippet: The photovoltaic and EIS parameters of the DSSCs based on Cu 2 CoSn(SeS) 4 and Cu 2 ZnSn(SeS) 4 nanocrystals and Pt counter electrodes.

Article Snippet: The X-ray diffraction (XRD) pattern of the nanocrystals was recorded with a Bruker Advance D8 diffractometer (Cu a source with 1.5406 wavelength) in powder mode.

Techniques:

Journal: Scientific Reports

Article Title: Penternary chalcogenides nanocrystals as catalytic materials for efficient counter electrodes in dye-synthesized solar cells

doi: 10.1038/srep29207

Figure Lengend Snippet: J–V characteristics of DSSCs employing Cu 2 CoSn(SeS) 4 and Cu 2 ZnSn(SeS) 4 nanocrystals- and Pt-based counter electrodes.

Article Snippet: The X-ray diffraction (XRD) pattern of the nanocrystals was recorded with a Bruker Advance D8 diffractometer (Cu a source with 1.5406 wavelength) in powder mode.

Techniques:

Journal: Pharmaceutics

Article Title: Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects

doi: 10.3390/pharmaceutics14091807

Figure Lengend Snippet: Formulation strategies to overcome fast-fed variability: prodrugs, cyclodextrins, osmotic delivery systems, amorphous solid dispersions, nanocrystal technology, and lipid-based systems.

Article Snippet: 24. , Rapamune ® , Sirolimus , Nanocrystal , Pfizer Inc., New York, NY, USA.

Techniques: Formulation

Journal: Pharmaceutics

Article Title: Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects

doi: 10.3390/pharmaceutics14091807

Figure Lengend Snippet: Marketed formulations with innovators who have successfully diminished fast-fed variability.

Article Snippet: 24. , Rapamune ® , Sirolimus , Nanocrystal , Pfizer Inc., New York, NY, USA.

Techniques: Drug Formulation, Dispersion, Formulation

Journal: Pharmaceutics

Article Title: Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects

doi: 10.3390/pharmaceutics14091807

Figure Lengend Snippet: Comparison of mean plasma concentrations of MK-0869 after oral dosing in beagle dogs ( n = 5) of suspension (●, fasted; o, fed) with NanoCrystal ® dispersion formulation (▾, fasted; ▿, fed). Reprinted with permission from Ref. . Copyright 2004, Elsevier.

Article Snippet: 24. , Rapamune ® , Sirolimus , Nanocrystal , Pfizer Inc., New York, NY, USA.

Techniques: Comparison, Clinical Proteomics, Suspension, Dispersion, Formulation

Journal: Pharmaceutics

Article Title: Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects

doi: 10.3390/pharmaceutics14091807

Figure Lengend Snippet: Formulation approaches for reducing fast-fed state variability with pharmacokinetic data.

Article Snippet: 24. , Rapamune ® , Sirolimus , Nanocrystal , Pfizer Inc., New York, NY, USA.

Techniques: Formulation, Dispersion

Journal: Pharmaceutics

Article Title: Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects

doi: 10.3390/pharmaceutics14091807

Figure Lengend Snippet: Patents filed exclusively to reduce fast-fed variability.

Article Snippet: 24. , Rapamune ® , Sirolimus , Nanocrystal , Pfizer Inc., New York, NY, USA.

Techniques: Formulation, Dispersion, Membrane, Emulsion